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Weaimtoprovideanoverviewofclinicalanddemographicalfeaturesandneuropathologicalresearchonfrontotemporaldementia
(FTD) from China over the past decade. We reviewed the demographic features, clinical presentations, and neuropathology of the
FTD-spectrum disorders from the 49 cases in China published since 1998. On the basis of these ﬁndings, we retrospect the history
and speculate on future progress in terms of FTD in China. We found that most published papers comprise case reports with a few
retrospective studies with small sample sizes. Behavior variant FTD (bvFTD) was the most common diagnostic subtype, of
which 35% were associated with amyotrophic lateral sclerosis or Parkinsonian syndrome. More than 47% patients with FTD had
age onset before 65. There were no diﬀerences in age of onset and sex distribution between diagnostic subtypes. The spectrum
of neuropathological diagnosis of bvFTD was frontotemporal lobe degeneration (FTLD) with tau protein or ubiquitin-immuno-
positive inclusions, and FTLD without intracellular inclusions. Median survival in bvFTD was 14 years. This paper provides an
overview of the current status and pointers for future research directions of FTD in China.
1.Introduction
Frontotemporaldementia(FTD)isaclinicallyandpatholog-
ically heterogeneous syndrome, characterized by progressive
decline in behavior or language functions associated with
frontal and temporal lobe degeneration (FTLD) [1–4]. Al-
thoughFTDwasﬁrstdescribedintheearly1900sasanearly-
onset disorder presenting before the age of 65, it has only
recently been appreciated as a leading cause of dementia,
and to be more common than previously recognized in ad-
vanced age [5]. Extensive worldwide studies on FTD have
been conducted, including epidemiological investigations,
cohort, and retrospective studies [6–8]. An interesting study,
intermsofthedistributionofFTDacrossfourethnicgroups,
claimed that it was as common in Asians as Caucasians [9].
Unfortunately, the epidemiological and demographic char-
acteristics of FTD in China have not been investigated to
date, where millions of patients suﬀer from Alzheimer’s dis-
ease (AD) [10, 11]. Given that FTD is the second most
common early-onset dementia after AD in the west [1–4],
the epidemiology of FTD of China is of considerable interest.
Since the introduction of standardized clinical diagnostic
criteriaforFTD[12]intoChina,therehasbeenanincreasing
interest in each of the three clinical variants: bvFTD [13–28],
semantic dementia (SD) [29–31], and progressive noninﬂu-
ent aphasia (PFNA) [32–37]. However, the level of research
has been limited to case reports and occasional retrospective
studies with small sample size. Diagnostic accuracy remains
a problem, and there is a lack of collaboration between study
centers or sites [27]. As a result, the proﬁle of FTD in China
remains obscure compared to the western world.
We reviewed the demographic features, clinical presen-
tations, and neuropathology of the FTD-spectrum disorders
fromthe49casesinChinapublishedsince1998.Onthebasis2 International Journal of Alzheimer’s Disease
of these ﬁndings, we speculate on future progress in China
and highlight the importance of international collaboration.
2. Methods
2.1. Search Strategy. We ﬁrst searched the Cochrane Library
(issue 1, 2011) for all systematic reviews that included cases
ofChinese FTD.Subsequently,wesearchedMEDLINE (1948
to present), EMBASE (1980 to present), PsychInFO (1987 to
present), and Chinese main medical databases: Chongqing
VIP Database (VIP), Wan Fang Database, Chinese hospital
knowledge database (CHKD), and Chinese biomedical data-
base (CBM-disc, 1978 to present) were searched to locate all
case reports or case series published in the last 12 years
(1998–2010) associated with FTD. The key words used in the
search included “frontotemporal lobar degeneration,” “fron-
totemporal dementia,” “Pick disease,” “progressive non-in-
ﬂuent aphasia,” “semantic dementia,” “primary progressive
aphasia,” and intervention-speciﬁc terms such as “China”
and “Chinese.” Every paper relating FTD was reviewed, and
the reference lists were also examined to identify possible
missed cases. No language restriction was applied.
2.2. Selection Criteria. Cases were included in this analysis
if patients satisﬁed the clinical diagnosis criteria of any of
the three variants of FTD [12]. For bvFTD, these include (1)
insidious onset and gradual progression; (2) early decline in
social interpersonal conduct; (3) early impairment in regula-
tion of personal conduct; (4) early emotional blunting; (5)
early loss of insight. Patients met the criteria for semantic
dementia if they exhibited (1) insidious onset and gradual
progression; (2) a language disorder characterized by empty
ﬂuent speech, loss of word meaning, or semantic para-
phasias; (3) a perceptual disorder characterized by impaired
recognition of familiar faces or object identity; (4) preserved
perceptual matching and drawing reproduction; (5) pre-
served single-word repetition; (6) preserved ability to read
aloud and write to dictation orthographically regular words.
Finally, patients meet the criteria for PNFA if they had (1)
insidious and gradual progression and (2) nonﬂuent spon-
taneous speech with at least one of agrammatism, phonemic
paraphasias, or anomia. Patients were diagnosed as probable
or possible amyotrophic lateral sclerosis (ALS) according to
the El Escorial criteria [38]. Our exclusion criteria were if (1)
the article had very limited information for FTD-related
studies [39, 40]; (2) the patient was not Han Chinese eth-
nicity [41]. Duplicated cases were only counted once, if it
appeared in several publications [42–45]. Overall, 49 cases
from 25 publications were included in this report.
2.3. Data Collection and Analysis. For each individual case of
FTD, the variables collected included age, gender, ethnicity,
family history of dementia, concomitant disorders, Mini-
Mental State Examination (MMSE) scores, and neuropatho-
logical diagnosis. Descriptive analysis was performed to ex-
amine the distribution of demographic characteristics. Cate-
gorical variables were compared using chi-square test, while
ANOVA was used for continuous variables. Kaplan-Meier
survival curve was used to assess the cumulative survival rate
of FTD.
3. Results
3.1. Diagnostic Subgroups. From January 1, 1998 to Decem-
ber 31, 2010, 49 patients of Han Chinese descent were diag-
nosed as having FTD across Northern and Eastern China.
The cases ﬁrst presented to memory clinics or department
of neurology (43/49); psychiatric clinics (3/49); GPs (general
practitioners); others (3/49).
Overall, bvFTD was the most common diagnostic sub-
group and accounted for 71.4% of all diagnoses (n = 35).
PNFA was the second most common (n = 8), followed by
SD(n = 6).OfthebvFTDpatients,17.1%(n = 6)and20.0%
(n = 7) were initially diagnosed possible ALS or Parkinso-
nian syndrome, respectively whereas none of SD or PNFA
patients had a concomitant ALS or Parkinsonian syndrome.
3 . 2 .A g eo fO n s e ta n dF a m i l yH i s t o r y .Age of onset ranged
from 20 to the eighth decade. Patients with bvFTD tended to
have a younger age of onset compared to patients with PNFA
or SD, but this was not statistically signiﬁcant as shown in
Table 1 (F = 2.523, P = 0.096). Approximately 45.7% of
bvFTD patients (n = 16), 37.5% of PNFA patients (n = 3),
and 66.7% of SD patients (n = 4) were diagnosed before the
age of 65. Overall, more than 47% FTD patients had the
disease before 65. Seven bvFTD cases, but not from the other
two groups, reported family histories.
3.3. Gender and Educations. Female patients comprised of
54.3%, 25%, and 50% of the bvFTD, PNFA, and SD sub-
types, respectively. No signiﬁcant diﬀerences in gender were
demonstrated by crosstab chi-square analyses by sites and
diagnosticsubgroups(Fisherexacttest,P = 0.387),although
there appeared to be less females in the PNFA subgroup.
Level of education varied greatly among patients with FTD,
some were university graduates, and some were illiterate.
3.4. MMSE Score at First Visit. Only 19 of the 49 cases were
presented with an MMSE score (9 with bvFTD; 6 with SD;
4w i t hP N F Ag r o u p ) .Ao n e - w a ya n a l y s i so fv a r i a n c es h o w e d
no signiﬁcant diﬀerence (13.9 ± 6.7; 15.3 ± 9.6; 15.7 ± 10.7)
between diagnostic subgroups (F = 0.092, P = 0.91).
3.5. Neuropathological Diagnosis and Survival Curve Analysis.
We found no reports of genetic screening. There are three
neuropathological studies reporting a total of ﬁve FTD cases
[14, 21, 46]. Table 2 summarizes the neuropathological diag-
nostic breakdown and demographic characteristics for the
ﬁve cases.
Median survival of 35 bvFTD cases presented in this
study was 14 years from symptom onset (Figure 1). The sur-
vival curve demonstrated that most cases would progress for
10–15 years from time of diagnosis till death.International Journal of Alzheimer’s Disease 3
Table 1: Demographic variables by diagnosis.
Variable\subgroups bvFTD PFNA SD Overall
MMSE score at the initial assessment 13.9 ±6.71 5 .3 ±9.61 5 .8 ±10.71 4 .7 ±8.0
Age at onset (years) 53.8 ±14.86 4 .1 ±10.16 3 .8 ±9.95 7 .8 ±13.8
Male/sex 16/35 6/8 3/6 25/49
Table 2: Characteristics by neuropathological diagnosis.
Neuropathological diagnosis Age at onset
(years)
Age at death
(years) Initial MMSE score Family history
(1) FTLD-τ 60, 72 76, 86 N/A, 8 No
(2) FTLD-U 58 61 22–30 No
(3) FTLD without intracellular inclusions 67, 43∗ 78, 46∗ N/A No
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Figure 1: Survival curve of bvFTD in the present study.
4. Discussion
The present study is the ﬁrst, to our knowledge, to summa-
rize demographic and clinical data from published cases in
China according to the diagnostic criteria for FTD and its
subgroups (bvFTD, PNFA, and SD). On the background of
low diagnostic accuracy and lack of epidemiological data,
this paper summarizes 49 cases from 24 articles and one
small size retrospective study from multiple centers that
demonstrated pathological features of FTD in China.
4.1. The Inﬂuences of Culture Background for Medical Service
for FTD in China. The present study appeared to yield sim-
ilar results compared to previous investigations from the
west. BvFTD was the most common diagnostic subgroup
and accounted for over half of all FTD diagnoses [6, 47]. SD
and PNFA were less common and accounted for 12.2% and
16.3%, respectively. Interestingly, patients often favored neu-
rology department or memory clinic over psychiatric clinic,
although the ﬁrst symptoms of FTD cases are frequently
behavioral and psychiatric changes. This paradoxical phe-
nomenon can be attributed to two potential factors. Firstly,
families in the Chinese culture are often ashamed of psychi-
atric diseases, hence favoring seeking help in neurology clin-
ics.Secondly,mostspecialistsforcognitivediseaseareneuro-
logists, and memory clinics or centers are generally run by
neurology departments in China. Hence, the culture back-
ground may play an important role in the paradigm of
delivering medical services to FTD patients in China, which
is similar to Alzheimer’s type dementia [48].
4.2. The Research History in Terms of FTD in China. The
earliest clinical and neuropathological studies of dementia in
China were by Tong and Wang in 1982 on Alzheimer’s type
dementia [49], and by Wang and her coworkers on Pick dis-
ease in 1993 [46]. The ﬁrst conﬁrmed case was a 93-year-old
woman with ten-year history characterized by impairment
of personal conduct and behavioral disorders with a positive
family history. She died of acute respiratory failure, and
autopsyresultsrevealedtypicalPickbodies.Inretrospect,the
earliestcasemighthavebeenobservedin1960butnotrecog-
nised as such at the time [25]. Dr. Xu reported a 40-year-old
male who presented with bizarre sexual behavior, as he bit
oﬀ one third of his newly wed wife tongue on the ﬁrst night
of their wedding. He was referred to the psychiatric clinic,
and a pneumoencephalography was performed with no ab-
normalities detected. He was suspected to have schizophre-
nia. Pneumoencephalography was repeated eight months
later, revealing asymmetric frontotemporal lobe atrophy
[25]. We suspect that FTD is not a rare disease in China, yet,
to our surprise, there were only 49 FTD cases reported from
China in the past 12 years. The overlap between FTD and
Alzheimer’s disease and psychiatric disorders, lack of neu-
ropathological conﬁrmation in most institutions in China,
and the fact that clinicians are not fully aware of this disorder
are the main causes for the underdiagnosis. Although brain4 International Journal of Alzheimer’s Disease
MRI has been taken as a routine clinical examination for
patients with dementia, most Chinese neurologists are short
of neuropsychological training for FTD diagnosis.
4.3.TheCurrentFeaturesofFTDinChina. Ourstudyshowed
that features of FTD in China are largely similar to those
reported in western countries with subtle diﬀerences [6, 38,
50]. As we gain more knowledge of FTD as a disease entity,
we have observed that more FTD cases have been diagnosed
compared to 20 years ago, and FTD has become one of most
frequently diagnosed neurodegenerative dementias after AD
in some memory clinics [51].
Similar to previous studies [6, 52], age of onset in FTD
varied widely from the 20s to the 80s. Overall, 23 of the 49
cases had an age of onset at 65 years or younger accounting
for 47% of the total. Patients with bvFTD appear to have a
younger age of onset compared to patients with PFNA and
SD. This is consistent with the average onset age of bvFTD,
PFNA, and SD is 57, 65, and 59 from a joint British-Austral-
ian study [52].
Except in bvFTD (20% positive family history), family
history does not appear to play an important role in PFNA
and SD. Unfortunately, the education levels obtained for
cases included in this study are ambiguous, as only the
occupations are available but not the exact level of education
received. Thus, we can only infer that the patients with FTD
included a wide range, from professors to the illiterate.
The distribution of FTD across sexes appears roughly
equal with some studies reporting a predominance in men
althoughthishasnotbeenaconsistentﬁnding[6,46,53,54].
Our study supported the equal sex distributions in bvFTD,
but gender predominance in the other two subtypes could
not be determined due to very small sample sizes.
M ediansurvi valinb vFTDinourstud ywas14y earsfr om
symptom onset which is consistent with other reports of
6–11 years [53–55]. ALS and parkinsonian syndrome can
coexistwithanyoftheFTDclinicalvariantsbutismostcom-
monly associated with bvFTD [56, 57]. Our study found that
17% (n = 6) of the bvFTD patients also had possible ALS,
whereas none of SD and none of PNFA patients had con-
comitant ALS. The bvFTD subgroup showed signiﬁcant
overlap with the atypical Parkinsonism associated with cor-
tical basal degeneration (CBD).
Neuropathological diagnosis was carried out in 5 cases of
bvFTD who showed gross atrophy of the frontal and anterior
temporallobesmacroscopically.Theneuropathologicaldiag-
noses included FTLD with tau-positive inclusions (FTLD-
τ),FTLDwithubiquitin-positiveandtau-negativeinclusions
(FTLD-U), and FTLD without tau-positive or ubiquitin-
positive inclusions. The spectrums of neuropathological
diagnosis are similar to previous studies [6].
4.4. The Progression of FTD Research in China. T h e r ei sa n
increasing trend for FTD research in China in the past ten
years. Unfortunately almost all research has focused on clini-
cal aspects rather than neuropathology. Compared to
Europe, North America, and Australia, studies of FTD in
China are in a preliminary stage. Our review highlights the
lackofneuropathologicalandgeneticstudiesandofauniﬁed
clinical rating scale for FTD. For example, a myriad of single
rating scales, including MMSE, Hasegawa Dementia Scale
(HDS) [16, 31], Wechsler Adult Memory Scale (WAMS)
[25], or the Chinese version of the revised Addenbrooke’s
Cognitive Examination (ACE-R) [58]w e r ee m p l o y e df o r
screening in diﬀerent memory clinics, which made compari-
son between cases diﬃcult.
Therefore, a crucial development will be the application
of consistent cognitive and behavioral rating scales for stud-
ies of FTD. This should be supplemented by genetic screen-
ing,particularlyformutationsoftheMAPTandprogranulin
in FTD patients with a strong family history. Longitudinal
clinical followup would achieve better management of FTD
and provide potential neuropathological diagnosis. We rec-
ommend the establishment of a multicenter work group in
China which, we feel, would be a more eﬃcient approach to
epidemiological and clinical studies in the future.
Inconclusion,thispaperprovidespreliminarydatatoaid
the understanding of the current situation of FTD in China.
This review highlighted the importance of establishing a
standardised protocol across diﬀerent clinical/medical re-
searchsitestoformalargecombinedcohort,inordertofacil-
itatetheexploringofepidemiological,clinical,andbiological
features of FTD, hence ultimately improving clinical diagno-
sis accuracy and quality of life for patients with FTD in the
world including China.
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